Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Matthias V Kopp"'
Autor:
Nina Schöbi, Andrea Duppenthaler, Matthias Horn, Andreas Bartenstein, Kristina Keitel, Matthias V. Kopp, Philipp K. A. Agyeman, Christoph Aebi
Publikováno v:
Infectious Disease Reports, Vol 16, Iss 5, Pp 864-869 (2024)
A Europe-wide outbreak of invasive pediatric group A streptococcal infections (iGAS) began in fall 2022. Here, we report the evolution of GAS hospitalizations in children and adolescents during the second outbreak year in 2023–2024 at a tertiary ce
Externí odkaz:
https://doaj.org/article/d337172883404dd28c6f92e23037fabb
Autor:
Martin Pech, Markus Weckmann, Inke R König, Andre Franke, Femke-Anouska Heinsen, Brian Oliver, Isabell Ricklefs, Oliver Fuchs, Klaus Rabe, Gesine Hansen, Erika V Mutius, Matthias V Kopp, ALLIANCE-study group
Publikováno v:
PLoS ONE, Vol 13, Iss 11, p e0205275 (2018)
Human rhinovirus infection (HRVI) plays an important role in asthma exacerbations and is thought to be involved in asthma development during early childhood. We hypothesized that HRVI causes differential DNA methylation and subsequently differential
Externí odkaz:
https://doaj.org/article/a0db5db5a191471e8a5e59c41b131414
Autor:
Eva Steinke, Olaf Sommerburg, Simon Y. Graeber, Cornelia Joachim, Christiane Labitzke, Gyde Nissen, Isabell Ricklefs, Isa Rudolf, Matthias V. Kopp, Anna-Maria Dittrich, Marcus A. Mall, Mirjam Stahl
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
BackgroundLung disease as major cause for morbidity in patients with cystic fibrosis (CF) starts early in life. Its large phenotypic heterogeneity is partially explained by the genotype but other contributing factors are not well delineated. The clos
Externí odkaz:
https://doaj.org/article/0025cdeb020e4c1d8071eb3fe20056a3
Autor:
Thomas Bahmer, Matthias V Kopp
Publikováno v:
Zeitschrift für Pneumologie. 20:3-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95d9525668dc07da9a7a78773c37b237
https://doi.org/10.1007/s10405-022-00482-w
https://doi.org/10.1007/s10405-022-00482-w
Autor:
Oliver Fuchs, Thomas Bahmer, Markus Weckmann, Anna-Maria Dittrich, Bianca Schaub, Barbara Rösler, Christine Happle, Folke Brinkmann, Isabell Ricklefs, Inke R. König, Henrik Watz, Klaus F. Rabe, Matthias V. Kopp, Gesine Hansen, Erika von Mutius, the ALLIANCE Study Group as part of the German Centre for Lung Research (DZL)
Publikováno v:
BMC Pulmonary Medicine, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background Asthma and wheezing disorders in childhood and adulthood are clinically heterogeneous regarding disease presentation, natural course, and response to treatment. Deciphering common disease mechanisms in distinct subgroups requires
Externí odkaz:
https://doaj.org/article/01de63a86e8046519637d2c654579709
Autor:
Natalie Baumann, Gyde Nissen, Matthias V. Kopp, Egbert Herting, Folke Brinkmann, Loretta Müller-Urech, Guido Stichtenoth, Markus Weckmann
Publikováno v:
Klinische Pädiatrie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dbe582d5c1dae88c2c554f97036629a3
https://doi.org/10.1055/s-0043-1761568
https://doi.org/10.1055/s-0043-1761568
Autor:
Gyde Nissen, Svenja Hinsenbrock, Tanja K. Rausch, Guido Stichtenoth, Isabell Ricklefs, Markus Weckmann, Andre Franke, Egbert Herting, Inke R. König, Matthias V. Kopp, Klaus F. Rabe, Wolfgang Göpel
Publikováno v:
NEJM Evidence. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::478d34d231d7bf132a9ca676c82cf248
https://doi.org/10.1056/evidoa2200279
https://doi.org/10.1056/evidoa2200279
Autor:
Andrea Felser, Philipp Agyeman, Matthias Horn, Enno Stranzinger, Matthias V. Kopp, Barbara Susanna Moser
Publikováno v:
Klinische Pädiatrie.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7667808bcd14d3d09766204042028d72
https://doi.org/10.1055/a-1970-6401
https://doi.org/10.1055/a-1970-6401
Autor:
Ruth Grychtol, Lennart Riemann, Svenja Gaedcke, Bin Liu, David DeLuca, Reinhold Förster, Nicole Maison, Dominik Thiele, Nikolas Jakobs, Thomas Bahmer, Meike Meyer, Svenja Foth, Stefanie Weber, Ernst Rietschel, Klaus F. Rabe, Matthias V. Kopp, Erika von Mutius, Anna-Maria Dittrich, Gesine Hansen
Publikováno v:
Journal of Allergy and Clinical Immunology.
BACKGROUND The Asthma Severity Scoring System (ASSESS) quantifies asthma severity in adolescents and adults. Scale performance in children < 12 years is unknown. OBJECTIVE To validate the ASSESS score in the All Age Asthma Cohort (ALLIANCE) and explo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::802090462b5b018d295aa8f910433a67
https://doi.org/10.1016/j.jaci.2023.01.027
https://doi.org/10.1016/j.jaci.2023.01.027
Autor:
Mirjam Stahl, Jobst Roehmel, Monika Eichinger, Felix Doellinger, Lutz Naehrlich, Matthias V Kopp, Anna-Maria Dittrich, Christopher Lee, Olaf Sommerburg, Simon Tian, Tu Xu, Pan Wu, Aniket Joshi, Partha Ray, Margaret E Duncan, Mark O Wielpütz, Marcus A Mall
Publikováno v:
Stahl, Mirjam; Roehmel, Jobst; Eichinger, Monika; Doellinger, Felix; Naehrlich, Lutz; Kopp, Matthias V; Dittrich, Anna-Maria; Lee, Christopher; Sommerburg, Olaf; Tian, Simon; Xu, Tu; Wu, Pan; Joshi, Aniket; Ray, Partha; Duncan, Margaret E; Wielpütz, Mark O; Mall, Marcus A (2023). Effects of Lumacaftor/Ivacaftor on Cystic Fibrosis Disease Progression in Children 2 through 5 Years of Age Homozygous for F508del-CFTR: A Phase 2 Placebo-controlled Clinical Trial. (In Press). Annals of the American Thoracic Society American Thoracic Society 10.1513/AnnalsATS.202208-684OC
RATIONALE Lumacaftor/ivacaftor (LUM/IVA) was shown to be safe and well tolerated in children 2 through 5 years of age with cystic fibrosis (CF) homozygous for F508del-CFTR in a phase 3 open-label study. Improvements in sweat chloride concentration, m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24e19cda186c75d3824ee95ea401bdc3
